Further, this miRNA modulates the mitochondrial functioning and metabolism [49,50], represses FGFRL1 and E2F3 expression, which inhibits cell apoptosis in hypoxia response [51,52], predicts poor survival in patients with breast cancer [53] and activates notch signalling pathway in angiogenesis [54]. The gene discussed is FGFRL1; the disease is breast cancer.